Myriad Genetics price target lowered to $14 from $24 at Piper Sandler
Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...
ETF Daily News6d
FY2024 EPS Estimates for Myriad Genetics Raised by Analyst
Check Out Our Latest Research Report on MYGN Myriad Genetics Trading Up 3.9 % Shares of NASDAQ:MYGN opened at $12.76 on Thursday. The company has a current ratio of 1.90, a quick ratio of 1.73 and ...
Forbes6d
Myriad Genetics
Myriad Genetics, Inc. is a molecular diagnostic company, which focuses on developing and marketing of novel predictive and personalized medicines and prognostic medicine tests. It operates through ...
Insider Monkey5d
Why Is Larry Robbins Bullish on Myriad Genetics, Inc. (MYGN) Now?
In this article, we are going to take a look at where Myriad Genetics, Inc. (NASDAQ:MYGN) stands against Larry Robbins’ other long-term stock picks. Larry Robbins is an American hedge fund ...
Yahoo Finance6d
Myriad Genetics, Inc. (MYGN)
In this article, we are going to take a look at where Myriad Genetics, Inc. (NASDAQ:MYGN) stands against Larry Robbins’ other long-term stock picks. Larry Robbins is an American hedge fund ...
Yahoo Finance1d
Myriad Genetics, Inc. (MYGN)
After hours: January 21 at 6:26:22 p.m. EST ...
Yahoo Finance6d
Myriad Genetics, Inc. (MYGN)
After hours: January 24 at 5:52:03 PM EST ...